|
January
12, 2001
Issue
#29
ORAL
ACTIVATION OF STEROIDS
by Pat
Arnold
The
subject of androgenic / anabolic steroids, and the different ways
that have been found to make them orally active, has been tossed
around lately on the internet mags.
This is an interesting topic to the science minded out there,
but beyond that, it also has potential utility to the prohormone
supplements. The
following is my take on the subject, including scientific references
and conjecture on my part.
The
problem with natural androgens
Testosterone
is the primary androgen in the human, and is the golden standard by
which all other steroids are compared.
Unfortunately, testosterone has very poor activity when taken
orally. This
necessitates that testosterone be administered by extra-oral means
such by injection, subcutaneous pellet implant, and transdermal gel
or patch.
17alpha
alkylated steroids
Scientists
have developed several synthetic testosterone derivatives that have
increased oral bioavailability. The first synthetic alteration that scientists utilized is
known as 17 alpha alkylation. 17a
alkylation involves the addition of an alkyl group (methyl or ethyl)
to the alpha position of the 17 carbon of the steroid backbone.
The alkylation at this position prevents the major route of
androgen deactivaton – oxidation to a 17-keto steroid - from
taking place. This
allows a large part of the steroid to avoid liver first pass
metabolic degradation. Examples
of 17a
alkylated steroids are methyltestosterone and Norethandrolone (Nilevar)
While
17a
alkylation is a very effective means of rendering steroids orally
active, it suffers from a serious drawback.
These steroids are all to some extent toxic to the liver.
Some are more toxic than others, but they all have been
associated with this problem. Jaundice
is not completely uncommon with the usage of this stuff, although
this condition is generally confined to individuals who are
predisposed to liver problems. Several cases of liver cancer have supposedly been linked to
17a
alkylated steroids, however, nothing definitive has been established
in this regard. On the
other hand, it is somewhat common to observe increases in blood test
indicators of liver stress such as BSP retention, and intrahepatic
cholestasis (a condition where bile clogs up and stops flowing from
the liver).
While
the dangers of 17a
alkylated steroids are not trivial, they still comprise some of the
most potent anabolic agents available, and therefore their use
continues. Most smart
bodybuilders are aware of the potential toxicities of these
steroids, and therefore they are judicious with their use of them.
Lipophilic
steroid derivatives
After
ingestion, most steroids make their way to the intestines where they
are absorbed into the portal circulation.
The portal circulation carries the steroid directly to the
liver, which is the workhouse of destructive metabolism and
inactivation of drugs. As
a result, if the steroid is not protected in some way, very little
will make it through the liver and into the rest of the body where
it can do its magic.
In
addition to the portal route, there is another route through which
substances can be absorbed into the body from the intestine.
If a substance is lipophilic (fat like) enough it will be
absorbed in the same manner that dietary fat is.
Dietary fat is incorporated into chylomicra, which are small
fat globules composed of protein and fat.
These chylomicra are absorbed into the lymphatic circulation,
which by passes the liver.
If you make a steroid lipophilic enough by altering its
structure, then it too will incorporate into chylomicra and absorb
into the lymphatic system. Once
in the lymphatic system it can cross over into the general blood
circulation, making it there without being subjected to the massive
metabolic breakdown in the liver.
Scientists
have found that by adding lipophilic side chains to steroids, they
will to some extent be absorbed into the lymphatic system.
If the side chain is linked on in such a way that it can
hydrolyze (break apart) easily after being absorbed, the steroid is
essentially rendered orally active.
Two side chains that have been utilized to increase the oral
bioavailability of steroids through increased hepatic absorption are
long chain alkyl ester groups, such as is seen with testosterone
undecanoate (andriol), and enyl ether groups, such as is seen with
quinbolone (anabolicum vaster).
The
term “orally active” is of course a relative term.
Lipophilically modified steroids are more orally active than
the free parent steroids, however, they are nowhere near as active
as the 17alpha-alkylated steroids.
Testosterone undecanoate (TU) is probably the most commonly
known lipophilically modified androgen, and it is not considered a
very potent compound (its recommended daily dosage is about 240mg). In fact, one study found the oral administration of
testosterone undecanoate led only to an absolute testosterone
bioavailability of 6.83 +/- 3.32%.
That is very slight, especially considering the fact that in
the same study they found the bioavailability of straight
testosterone to be 3.56 +/- 2.45% (Eur J Drug Metab Pharmacokinet
1986 Apr-Jun;11(2):145-9). That
means TU is just a little less than twice as orally active as free
testosterone, which is unimpressive to say the least.
The
other problem with lipophilic steroid preparations is the high
variability in absorption from one person to another.
In other words, one guy might absorb the stuff very well
while the other guy might absorb very little.
There is also high variation within individuals themselves,
depending on their gastrointestinal condition when they take the
stuff. In another
study, ten post-menopausal women were given 40 mg of TU and their
peak blood values were recorded.
The values varied widely - more than ten fold (range:
5.8-64.0 nmol/L) - amongst the subjects (J Clin Endocrinol Metab
1998 Nov;83(11): 3920-4).
There
is no specific data I can find on the bioavailabilty of enyl ether
compounds, but since their mode of action is identical to long chain
alkyl ester compounds like TU, it is a fair assumption that they too
are not outstandingly high in oral bioavailability, or in
consistency of absorption. What
I do know is that the one and only enyl ether oral steroid on the
market today (quinbolone) is generally regarded by European
bodybuilders / athletes as too weak to even
bother taking.
Ring
A modified steroids
There
is one more class of anabolic / androgenic steroids that are orally
active. These have
unique structural modifications in the steroid A ring.
What these modifications do is help preserve the steroids
17beta hydroxyl group, and minimize oxidation to the inactive
17-keto form.
Androgens
such as testosterone exist in the body in equilibrium between their
active 17beta hydroxyl form and the inactive 17-keto form.
Normally,
the equilibrium lies pretty far to the right (formation of inactive
17 keto steroid), however some steroids have certain modifications
made in the A ring that alter this equilibrium by shifting it
heavily to the left (towards the formation of active 17beta hydroxyl
steroid).
The
most common A-ring modifications that shift the 17beta hydroxyl /
17-keto equilibrium to the left are methylation at the 1alpha
position, and unsaturation (double bond) in the 1(2) position (Acta
Endocr, 41, (1962) 494). Examples
of orally active steroids that contain one or more these
modifications include methenolone (primobolan), mesterolone (proviron),
and 1-testosterone.
You
probably have heard of mesterolone and methenolone, but it is
doubtful you have ever heard of 1-testosterone. 1-testosterone is a very interesting compound, not just
because it is orally active but also because it is very anabolic.
It has been reported to be over 7 times as anabolic as
testosterone in a study funded by the pharmaceutical giant Searle (J
Org Chem, 27 (1962) 248). Furthermore,
being a 5alpha reduced steroid, it should not aromatize to
estrogens.
BACK
TO CURRENT ISSUE
|